Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma

Background: Hepatic arterial infusion chemotherapy (HAIC) with cisplatin, fluorouracil, and leucovorin (FOLFOX) demonstrated promising efficacy against advanced hepatocellular carcinoma (HCC) as an alleviative treatment. We aimed to explore the survival benefit of preoperative FOLFOX-HAIC and establ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zili, Yang, Zhenyun, Pan, Yangxun, Fu, Yizhen, Wang, Jiongliang, Zhou, Zhongguo, Chen, Minshan, Hu, Dandan, Zhang, Yaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338864/
https://www.ncbi.nlm.nih.gov/pubmed/37456741
http://dx.doi.org/10.3389/fphar.2023.1210835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338864/
https://www.ncbi.nlm.nih.gov/pubmed/37456741
http://dx.doi.org/10.3389/fphar.2023.1210835

Ejemplares similares